Scholar Rock Holding Corporation, a late-stage biopharmaceutical company, is set to participate in the 46th Annual Goldman Sachs Global Healthcare Conference. The event, taking place on Wednesday, June 11 at 9:20 a.m. ET in Miami, Florida, will feature a fireside chat with CEO David L. Hallal and members of the management team. They will discuss the company's focus on developing and commercializing apitegromab for patients with spinal muscular atrophy $(SMA)$ and other severe neuromuscular diseases.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scholar Rock Holding Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250605180760) on June 05, 2025, and is solely responsible for the information contained therein.